Cas:390766-89-9 (2R,5R)-5-benzyl-2-tert-butyl-3-methylimidazolidin-4-one manufacturer & supplier

Chemical Name:(2R,5R)-5-benzyl-2-tert-butyl-3-methylimidazolidin-4-one

CAS.NO:390766-89-9

Synonyms:(2R,5R)-5-benzyl-2-tert-butyl-3-methylimidazolidin-4-one

Molecular Formula:C₁₅H₂₂N₂O

Molecular Weight:246.34800

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:378ºC at 760 mmHg

Density:1.04g/cm3

Index of Refraction:1.528

PSA:32.34000

Exact Mass:246.17300

LogP:2.29820

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like (2R,5R)-5-benzyl-2-tert-butyl-3-methylimidazolidin-4-one chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(2R,5R)-5-benzyl-2-tert-butyl-3-methylimidazolidin-4-one physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(2R,5R)-5-benzyl-2-tert-butyl-3-methylimidazolidin-4-one Use and application,(2R,5R)-5-benzyl-2-tert-butyl-3-methylimidazolidin-4-one technical grade,usp/ep/jp grade.

Related News: Ten domestic API leading enterprises of CSPC, Puluo Pharmaceutical, Huahai Pharmaceutical, Chuang Nuo Pharmaceutical, Federal Pharmaceuticals, Zhejiang Pharmaceutical, Yifan Pharmaceutical, Jiangxi Tianxin, Zhejiang Chemical Industry, and Xinhua Pharmaceutical rank among China’s API exporters The top ten in the list. (2R,5R)-5-benzyl-2-tert-butyl-3-methylimidazolidin-4-one manufacturer Vietnam recently barred almost all flights to and from mainland China, Hong Kong and Macau until May 1, according to the United States Federal Aviation Administration. (2R,5R)-5-benzyl-2-tert-butyl-3-methylimidazolidin-4-one supplier Ten domestic API leading enterprises of CSPC, Puluo Pharmaceutical, Huahai Pharmaceutical, Chuang Nuo Pharmaceutical, Federal Pharmaceuticals, Zhejiang Pharmaceutical, Yifan Pharmaceutical, Jiangxi Tianxin, Zhejiang Chemical Industry, and Xinhua Pharmaceutical rank among China’s API exporters The top ten in the list. (2R,5R)-5-benzyl-2-tert-butyl-3-methylimidazolidin-4-one vendor In March 2021, Reuters reported that a former Lilly human resources officer, Amrit Mula, had identified internally some of the same violations later documented by the FDA. Mula was forced out of the company in early 2019 after Lilly executives sought to downplay her findings, according to a letter demanding compensation for damages that her attorneys sent to the company. (2R,5R)-5-benzyl-2-tert-butyl-3-methylimidazolidin-4-one factory Zhejiang Huahai Pharmaceutical: It is a leading company in domestic APIs, especially in the field of cardiovascular drugs.